HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dale G Nagle Selected Research

Proteins (Proteins, Gene)

9/2011Mitochondrial respiration inhibitors suppress protein translation and hypoxic signaling via the hyperphosphorylation and inactivation of translation initiation factor eIF2α and elongation factor eEF2.
5/2010The alternative medicine pawpaw and its acetogenin constituents suppress tumor angiogenesis via the HIF-1/VEGF pathway.
12/2009The Caulerpa pigment caulerpin inhibits HIF-1 activation and mitochondrial respiration.
8/2005Saururus cernuus lignans--potent small molecule inhibitors of hypoxia-inducible factor-1.
6/2005Terpenoid tetrahydroisoquinoline alkaloids emetine, klugine, and isocephaeline inhibit the activation of hypoxia-inducible factor-1 in breast tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dale G Nagle Research Topics

Disease

29Neoplasms (Cancer)
01/2024 - 05/2004
29Hypoxia (Hypoxemia)
11/2018 - 05/2004
19Breast Neoplasms (Breast Cancer)
11/2018 - 12/2004
2Triple Negative Breast Neoplasms
01/2024 - 01/2021
2Melanoma (Melanoma, Malignant)
01/2024 - 01/2021
2Inflammation (Inflammations)
01/2017 - 06/2006
2Psoriasis (Pustulosis Palmaris et Plantaris)
06/2006 - 08/2005
2Mycoses (Diseases, Fungus)
04/2006 - 09/2003
1Neoplasm Metastasis (Metastasis)
01/2024
1Carcinoma (Carcinomatosis)
01/2024
1Stomach Neoplasms (Stomach Cancer)
05/2023
1Squamous Cell Carcinoma of Head and Neck
11/2022
1Colorectal Neoplasms (Colorectal Cancer)
01/2022
1Asthma (Bronchial Asthma)
01/2017
1Eosinophilia
01/2017
1Respiratory Hypersensitivity
01/2017
1Hypersensitivity (Allergy)
12/2012
1Prostatic Neoplasms (Prostate Cancer)
03/2008
1Weight Loss (Weight Reduction)
09/2006

Drug/Important Bio-Agent (IBA)

14Transcription Factors (Transcription Factor)IBA
01/2017 - 05/2004
9LipidsIBA
01/2024 - 12/2006
7Chelating AgentsIBA
09/2012 - 05/2004
7IronIBA
09/2012 - 05/2004
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2015 - 12/2004
5Peptides (Polypeptides)IBA
01/2024 - 01/2021
5Antineoplastic Agents (Antineoplastics)IBA
09/2012 - 05/2004
5Proteins (Proteins, Gene)FDA Link
09/2011 - 06/2005
4Oxygen (Dioxygen)IBA
06/2013 - 12/2004
2Adenosine Triphosphate (ATP)IBA
01/2024 - 12/2012
2AntibodiesIBA
01/2022 - 01/2021
2MicroRNAs (MicroRNA)IBA
09/2021 - 01/2020
2SesterterpenesIBA
08/2013 - 11/2007
2CoumarinsIBA
02/2011 - 11/2010
2Terpenes (Terpenoids)IBA
11/2008 - 06/2005
2laurenditerpenolIBA
12/2007 - 12/2004
2TeaIBA
09/2006 - 12/2004
2manassantin BIBA
08/2005 - 05/2004
1MicellesIBA
01/2024
1Adenosine (Adenocard)FDA LinkGeneric
01/2024
1AntigensIBA
01/2024
1ciforadenantIBA
01/2024
1Proteolysis Targeting ChimeraIBA
05/2023
1CrizotinibIBA
05/2023
1snake venom protein C activatorIBA
11/2022
1PolymersIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
09/2021
1Circular RNAIBA
09/2021
1Peptide Hydrolases (Proteases)FDA Link
01/2021
1Wasp Venoms (Venom, Wasp)IBA
01/2021
1Histone Deacetylases (Histone Deacetylase)IBA
11/2018
1Histone Deacetylase InhibitorsIBA
11/2018
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2018
1STA 9090IBA
01/2018
1tanespimycin (17AAG)IBA
01/2018
1Peroxidase (Myeloperoxidase)IBA
01/2017
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2017
1Interleukin-5 (Interleukin 5)IBA
01/2017
1Interleukin-13IBA
01/2017
1sampangineIBA
12/2015
1kalkitoxinIBA
03/2015
1Cytostatic AgentsIBA
03/2015
1thorectidaeolide AIBA
08/2013
14-acetoxythorectidaeolide AIBA
08/2013
1luffariellolideIBA
08/2013
1PoisonsIBA
04/2013
1auraptenIBA
04/2013
1RotenoneIBA
12/2012
1Lactic Acid (Lactate)FDA LinkGeneric
12/2012
1Glucose (Dextrose)FDA LinkGeneric
12/2012
1thyrsiferolIBA
06/2011
1coumarinIBA
11/2010
1Mammea E-BB compoundIBA
11/2010
1mycothiazoleIBA
08/2010
1AcetogeninsIBA
05/2010
1annonacinIBA
05/2010
1Complex MixturesIBA
05/2010
1caulerpinIBA
12/2009
1Conditioned Culture MediaIBA
12/2009
1furospongolideIBA
11/2008
1Electron Transport Complex I (NADH-CoQ Reductase)IBA
11/2008
1matrigelIBA
03/2008
1CarbamatesIBA
03/2008
1latrunculin A (LAT-A)IBA
03/2008
1naphthaleneIBA
11/2007
1LuciferasesIBA
09/2007
1PeroxidesIBA
01/2007
1TriterpenesIBA
12/2006
1AntioxidantsIBA
09/2006
1Interleukin-15 (Interleukin 15)IBA
06/2006
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
06/2006
1carbazoleIBA
06/2006
1Coal Tar (Estar)IBA
06/2006
1AzolesIBA
04/2006
1psammaplin AIBA
04/2006
1PPAR gammaIBA
04/2006

Therapy/Procedure

4Therapeutics
01/2017 - 08/2005
3Immunotherapy
01/2024 - 01/2021
2Drug Therapy (Chemotherapy)
01/2021 - 07/2004
2Chemoprevention
09/2006 - 12/2004
1Complementary Therapies (Alternative Medicine)
05/2010